Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity.
dc.contributor.author | Guo, Hao | |
dc.contributor.author | Verhoek, Iris C | |
dc.contributor.author | Prins, Gerian G H | |
dc.contributor.author | van der Vlag, Ramon | |
dc.contributor.author | van der Wouden, Petra E | |
dc.contributor.author | van Merkerk, Ronald | |
dc.contributor.author | Quax, Wim J | |
dc.contributor.author | Olinga, Peter | |
dc.contributor.author | Hirsch, Anna K H | |
dc.contributor.author | Dekker, Frank J | |
dc.date.accessioned | 2020-08-19T09:08:26Z | |
dc.date.available | 2020-08-19T09:08:26Z | |
dc.date.issued | 2019-04-19 | |
dc.identifier.citation | J Med Chem. 2019;62(9):4624-4637. doi:10.1021/acs.jmedchem.9b00212. | en_US |
dc.identifier.pmid | 30964295 | |
dc.identifier.doi | 10.1021/acs.jmedchem.9b00212 | |
dc.identifier.uri | http://hdl.handle.net/10033/622415 | |
dc.description.abstract | Various mechanisms for regulated cell death include the formation of oxidative mediators such as lipid peroxides and nitric oxide (NO). In this respect, 15-lipoxygenase-1 (15-LOX-1) is a key enzyme that catalyzes the formation of lipid peroxides. The actions of these peroxides are interconnected with nuclear factor-κB signaling and NO production. Inhibition of 15-LOX-1 holds promise to interfere with regulated cell death in inflammatory conditions. In this study, a novel potent 15-LOX-1 inhibitor, 9c (i472), was developed and structure-activity relationships were explored. In vitro, this inhibitor protected cells from lipopolysaccharide-induced cell death, inhibiting NO formation and lipid peroxidation. Thus, we provide a novel 15-LOX-1 inhibitor that inhibits cellular NO production and lipid peroxidation, which set the stage for further exploration of these mechanisms. | en_US |
dc.language.iso | en | en_US |
dc.publisher | ACS | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.title | Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity. | en_US |
dc.type | Article | en_US |
dc.type | Other | en_US |
dc.identifier.eissn | 1520-4804 | |
dc.contributor.department | HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany. | en_US |
dc.identifier.journal | Journal of medicinal chemistry | en_US |
dc.source.volume | 62 | |
dc.source.issue | 9 | |
dc.source.beginpage | 4624 | |
dc.source.endpage | 4637 | |
refterms.dateFOA | 2020-08-19T09:08:27Z | |
dc.source.journaltitle | Journal of medicinal chemistry | |
dc.source.country | United States |